Paris, France – August 29, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of EUR 1 billion of notes, due 2020, bearing interest at an annual rate of 1.875%.
The issue is drawn under the Company’s Euro Medium Term Note Programme. Sanofi intends to use the net proceeds of the offering for general corporate purposes, including the repayment of existing borrowings.
ING, Natixis, Société Générale and Unicredit acted as joint bookrunners for the offering. RBS and Santander were co-lead managers for the offering.